Determinants of hypomagnesemia in patients with type 2 diabetes mellitus

European Journal of Endocrinology

Volumn 176, Issue 1, 2017, Pages 11-19

  Kurstjens, Steef ^a   De Baaij, Jeroen H F ^a   Bouras, Hacene ^a   Bindels, René J M ^a   Tack, Cees J J ^b   Hoenderop, Joost G J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; MAGNESIUM; METFORMIN; PROTON PUMP INHIBITOR; SODIUM; TRIACYLGLYCEROL; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG USE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; HYPOMAGNESEMIA; MAGNESIUM BLOOD LEVEL; MAGNESIUM EXCRETION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SPECTROPHOTOMETRY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; MIDDLE AGED;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MAGNESIUM; MALE; METFORMIN; MIDDLE AGED; TRIGLYCERIDES;

EID: 85002261173     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-16-0517     Document Type: Article

References (53)

1. Gommers LM, Hoenderop JG, Bindels RJ & de Baaij JH. Hypomagnesemia in type 2 diabetes: a vicious circle? Diabetes 2016 65 3-13. (doi:10.2337/db15-1028)
2. Martin HE & Wertman M. Serum potassium, magnesium, and calcium levels in diabetic acidosis. Journal of Clinical Investigation 1947 26 217-228. (doi:10.1172/JCI101799)
3. Pham PC, Pham PM, Pham SV, Miller JM & Pham PT. Hypomagnesemia in patients with type 2 diabetes. Clinical Journal of the American Society of Nephrology 2007 2 366-373. (doi:10.2215/CJN.02960906)
4. Mather HM, Nisbet JA, Burton GH, Poston GJ, Bland JM, Bailey PA & Pilkington TR. Hypomagnesaemia in diabetes. Clinica Chimica Acta 1979 95 235-242. (doi:10.1016/0009-8981(79)90364-4)
5. Grober U, Schmidt J & Kisters K. Magnesium in prevention and therapy. Nutrients 2015 7 8199-8226. (doi:10.3390/nu7095388)
6. Guerrero-Romero F, Tamez-Perez HE, Gonzalez-Gonzalez G, Salinas-Martinez AM, Montes-Villarreal J, Trevino-Ortiz JH & Rodriguez-Moran M. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes and Metabolism 2004 30 253-258. (doi:10.1016/S1262-3636(07)70116-7)
7. Paolisso G, Sgambato S, Gambardella A, Pizza G, Tesauro P, Varricchio M & D'Onofrio F. Daily magnesium supplements improve glucose handling in elderly subjects. American Journal of Clinical Nutrition 1992 55 1161-1167.
8. Hruby A, Meigs JB, O'Donnell CJ, Jacques PF & McKeown NM. Higher magnesium intake reduces risk of impaired glucose and insulin metabolism and progression from prediabetes to diabetes in middle-aged americans. Diabetes Care 2014 37 419-427. (doi:10.2337/dc13-1397)
9. Pham PC, Pham PM, Pham PA, Pham SV, Pham HV, Miller JM, Yanagawa N & Pham PT. Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2. Clinical Nephrology 2005 63 429-436. (doi:10.5414/CNP63429)
10. Liamis G, Rodenburg EM, Hofman A, Zietse R, Stricker BH & Hoorn EJ. Electrolyte disorders in community subjects: prevalence and risk factors. American Journal of Medicine 2013 126 256-263. (doi:10.1016/j.amjmed.2012.06.037)
11. Peacock JM, Folsom AR, Arnett DK, Eckfeldt JH & Szklo M. Relationship of serum and dietary magnesium to incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study. Annals of Epidemiology 1999 9 159-165. (doi:10.1016/S1047-2797(98)00040-4)
12. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG & Metcalf PA. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. Journal of Clinical Epidemiology 1995 48 927-940. (doi:10.1016/0895-4356(94)00200-A)
13. de Roij van Zuijdewijn CL, Grooteman MP, Bots ML, Blankestijn PJ, Steppan S, Buchel J, Groenwold RH, Brandenburg V, van den Dorpel MA, Ter Wee PM et al. Serum magnesium and sudden death in European hemodialysis patients. PLoS ONE 2015 10 e0143104. (doi:10.1371/journal.pone.0143104)
14. Massy ZA & Drueke TB. Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Clinical Kidney Journal 2012 5 i52-i61. (doi:10.1093/ndtplus/sfr167)
15. Liamis G, Liberopoulos E, Barkas F & Elisaf M. Diabetes mellitus and electrolyte disorders. World Journal of Clinical Cases 2014 2 488-496. (doi:10.12998/wjcc.v2.i10.488)
16. Viering DH, de Baaij JH, Walsh SB, Kleta R & Bockenhauer D. Genetic causes of hypomagnesemia, a clinical overview. Pediatric Nephrology 2016. In press. (doi:10.1007/s00467-016-3416-3)
17. Marier JR. Magnesium content of the food supply in the modern-day world. Magnesium 1986 5 1-8.
18. Foss MT & Clement KD. Metformin as a cause of late-onset chronic diarrhea. Pharmacotherapy 2001 21 1422-1424. (doi:10.1592/phco.21.17.1422.34430)
19. Svare A. A patient presenting with symptomatic hypomagnesemia caused by metformin-induced diarrhoea: a case report. Cases Journal 2009 2 156. (doi:10.1186/1757-1626-2-156)
20. Vinik AI, Maser RE, Mitchell BD & Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003 26 1553-1579. (doi:10.2337/diacare.26.5.1553)
21. Lameris AL, Monnens LA, Bindels RJ & Hoenderop JG. Drug-induced alterations in Mg2+ homoeostasis. Clinical Science 2012 123 1-14. (doi:10.1042/CS20120045)
22. Nijenhuis T, Renkema KY, Hoenderop JG & Bindels RJ. Acid-base status determines the renal expression of Ca2+ and Mg2+ transport proteins. Journal of the American Society of Nephrology 2006 17 617-626. (doi:10.1681/ASN.2005070732)
23. Nair AV, Hocher B, Verkaart S, van Zeeland F, Pfab T, Slowinski T, Chen YP, Schlingmann KP, Schaller A, Gallati S et al. Loss of insulin-induced activation of TRPM6 magnesium channels results in impaired glucose tolerance during pregnancy. PNAS 2012 109 11324-11329. (doi:10.1073/pnas.1113811109)
24. Wilcox G. Insulin and insulin resistance. Clinical Biochemist Reviews 2005 26 19-39.
25. Nyenwe EA, Jerkins TW, Umpierrez GE & Kitabchi AE. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism 2011 60 1-23. (doi:10.1016/j.metabol.2010.09.010)
26. DeFronzo RA, Cooke CR, Andres R, Faloona GR & Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. Journal of Clinical Investigation 1975 55 845-855. (doi:10.1172/JCI107996)
27. Nijenhuis T, Vallon V, van der Kemp AW, Loffing J, Hoenderop JG & Bindels RJ. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. Journal of Clinical Investigation 2005 115 1651-1658. (doi:10.1172/JCI24134)
28. Martin BJ & Milligan K. Diuretic-associated hypomagnesemia in the elderly. Archives of Internal Medicine 1987 147 1768-1771. (doi:10.1001/archinte.1987.00370100082014)
29. Cohen N, Almoznino-Sarafian D, Zaidenstein R, Alon I, Gorelik O, Shteinshnaider M, Chachashvily S, Averbukh Z, Golik A, Chen-Levy Z & Modai D. Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation. Heart 2003 89 411-416. (doi:10.1136/heart.89.4.411)
30. Hess MW, Hoenderop JG, Bindels RJ & Drenth JP. Systematic review: hypomagnesaemia induced by proton pump inhibition. Alimentary Pharmacology and Therapeutics 2012 36 405-413. (doi:10.1111/j.1365-2036.2012.05201.x)
31. van't Riet E, Schram MT, Abbink EJ, Admiraal WM, Dijk-Schaap MW, Holleman F, Nijpels G, Ozcan B, Pijl H, Schaper NC et al. The diabetes pearl: diabetes biobanking in The Netherlands. BMC Public Health 2012 12 949. (doi:10.1186/1471-2458-12-949)
32. Organization WH. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. Geneva, Switzerland: World Health Org, 2006.
33. Ayuk J & Gittoes NJ. Contemporary view of the clinical relevance of magnesium homeostasis. Annals of Clinical Biochemistry 2014 51 179-188. (doi:10.1177/0004563213517628)
34. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Diseases 2002 39 S1-S266.
35. de Lordes Lima M, Cruz T, Pousada JC, Rodrigues LE, Barbosa K & Cangucu V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 1998 21 682-686. (doi:10.2337/diacare.21.5.682)
36. McNair P, Christensen MS, Christiansen C, Madsbad S & Transbol I. Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis. European Journal of Clinical Investigation 1982 12 81-85. (doi:10.1111/j.1365-2362.1982.tb00942.x)
37. Bo S & Pisu E. Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Current Opinion in Lipidology 2008 19 50-56. (doi:10.1097/MOL.0b013e3282f33ccc)
38. Tin A, Kottgen A, Folsom AR, Maruthur NM, Tajuddin SM, Nalls MA, Evans MK, Zonderman AB, Friedrich CA, Boerwinkle E et al. Genetic loci for serum magnesium among African-Americans and gene-environment interaction at MUC1 and TRPM6 in European-Americans: the Atherosclerosis Risk in Communities (ARIC) study. BMC Genetics 2015 16 56. (doi:10.1186/s12863-015-0219-7)
39. Meyer TE, Verwoert GC, Hwang SJ, Glazer NL, Smith AV, van Rooij FJ, Ehret GB, Boerwinkle E, Felix JF, Leak TS et al. Genome-wide association studies of serum magnesium, potassium, and sodium concentrations identify six Loci influencing serum magnesium levels. PLoS Genetics 2010 6. (doi:10.1371/journal.pgen.1001045)
40. Akizawa Y, Koizumi S, Itokawa Y, Ojima T, Nakamura Y, Tamura T & Kusaka Y. Daily magnesium intake and serum magnesium concentration among Japanese people. Journal of Epidemiology 2008 18 151-159. (doi:10.2188/jea.JE2007381)
41. Corica F, Corsonello A, Ientile R, Cucinotta D, Di Benedetto A, Perticone F, Dominguez LJ & Barbagallo M. Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. Journal of the American College of Nutrition 2006 25 210-215. (doi:10.1080/07315724.2006.10719534)
42. Guerrero-Romero F & Rodriguez-Moran M. Low serum magnesium levels and metabolic syndrome. Acta Diabetologica 2002 39 209-213. (doi:10.1007/s005920200036)
43. Lal J, Vasudev K, Kela AK & Jain SK. Effect of oral magnesium supplementation on the lipid profile and blood glucose of patients with type 2 diabetes mellitus. Journal of the Association of Physicians of India 2003 51 37-42.
44. Song Y, He K, Levitan EB, Manson JE & Liu S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabetic Medicine 2006 23 1050-1056. (doi:10.1111/j.1464-5491.2006.01852.x)
45. Vinals F, Camps M, Testar X, Palacin M & Zorzano A. Effect of cations on the tyrosine kinase activity of the insulin receptor: inhibition by fluoride is magnesium dependent. Molecular and Cellular Biochemistry 1997 171 69-73. (doi:10.1023/A:1006836001489)
46. Vicario PP & Bennun A. Separate effects of Mg2+, MgATP, and ATP4- on the kinetic mechanism for insulin receptor tyrosine kinase. Archives of Biochemistry and Biophysics 1990 278 99-105. (doi:10.1016/0003-9861(90)90236-R)
47. Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, Srivali N, Edmonds PJ, Ungprasert P, O'Corragain OA, Korpaisarn S & Erickson SB. Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies. Renal Failure 2015 37 1237-1241. (doi:10.3109/0886022X.2015.1057800)
48. Fagan TE & Romani A. Activation of Na(+)- and Ca(2+)-dependent Mg(2+) extrusion by alpha(1)- and beta-adrenergic agonists in rat liver cells. American Journal of Physiology: Gastrointestinal and Liver Physiology 2000 279 G943-G950.
49. Lipworth BJ, McDevitt DG & Struthers AD. Prior treatment with diuretic augments the hypokalemic and electrocardiographic effects of inhaled albuterol. American Journal of Medicine 1989 86 653-657. (doi:10.1016/0002-9343(89)90438-5)
50. McBain AM, Brown IR, Menzies DG & Campbell IW. Effects of improved glycaemic control on calcium and magnesium homeostasis in type II diabetes. Journal of Clinical Pathology 1988 41 933-935. (doi:10.1136/jcp.41.9.933)
51. Swaminathan R. Magnesium metabolism and its disorders. Clinical Biochemist Reviews 2003 24 47-66.
52. Simental-Mendia LE, Rodriguez-Moran M & Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metabolic Syndrome and Related Disorders 2008 6 299-304. (doi:10.1089/met.2008.0034)
53. Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, Martinez-Abundis E, Ramos-Zavala MG, Hernandez-Gonzalez SO, Jacques-Camarena O & Rodriguez-Moran M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. Journal of Clinical Endocrinology and Metabolism 2010 95 3347-3351. (doi:10.1210/jc.2010-0288)